Ronald G. Worton

6.1k citations

88 papers · 5.0k indexed · 1 hit paper · h-index 35

Molecular Biology top 1%
- Muscle Physiology and Disorders 44
- CRISPR and Genetic Engineering 13
- RNA modifications and cancer 12
- RNA Research and Splicing 11
Genetics top 1%
- Neurogenetic and Muscular Disorders Research 11
- Virus-based gene therapy research 8
- Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities 7
Genetics top 1%
- Neurogenetic and Muscular Disorders Research 11
- Virus-based gene therapy research 8
- Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities 7
Cardiology and Cardiovascular Medicine top 2%
- Cardiomyopathy and Myosin Studies 9
Cellular and Molecular Neuroscience top 5%

Co-authors: Peter N. Ray Catherine Duff Arthur H.M. Burghes Elizabeth E. Zubrzycka‐Gaarn George Karpati Margaret Thompson Dennis E. Bulman Henry J. Klamut
Cited by: Molecular Biology Genetics
Partner nations: Canada United States United Kingdom

In The Last Decade

Ronald G. Worton

86 papers receiving 4.8k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

1988 The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle

Peers

Countries citing papers authored by Ronald G. Worton

Since Specialization

Citations

This map shows the geographic impact of Ronald G. Worton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald G. Worton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald G. Worton more than expected).

Fields of papers citing papers by Ronald G. Worton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald G. Worton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald G. Worton. The network helps show where Ronald G. Worton may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ronald G. Worton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ronald G. Worton Line = papers co-authored together Ronald G. Worton links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The Mouse Dystrophin Muscle Promoter/Enhancer Drives Expression of Mini-dystrophin in Transgenic mdx Mice and Rescues the Dystrophy in These Mice Carrie L. Anderson,Yves De Repentigny,Carlo Cifelli,Philip Marshall,Jean‐Marc Renaud,Ronald G. Worton,Rashmi Kothary	2006	13
2	The Mouse Dystrophin Enhancer Is Regulated by MyoD, E-box-binding Factors, and by the Serum Response Factor Philip Marshall,Nathalie Chartrand,Ronald G. Worton	2001	19
3	On Discovery, Genomes, The Society, and Society* Ronald G. Worton	2001	1
4	Legal Rights and Human Genetic Material. Ronald G. Worton	1997	14
5	Modulation of the Specificity and Activity of a Cellular Promoter in an Adenoviral Vector Qinwei Shi,Yanchun Wang,Ronald G. Worton	1997	52
6	Assignment of the Gene (UQCRFS1) for the Rieske Iron-Sulfur Protein Subunit of the Mitochondrial Cytochrome bc1 Complex to the 22q13 and 19q12-q13.1 Regions of the Human Genome Alessandra M.V. Duncan,L. Anderson,Catherine Duff,Takayuki Ozawa,Hiroshi Suzuki,Ronald G. Worton,Rima Rozen	1994	5
7	Myoblast transfer in duchenne muscular dystrophy George Karpati,Djordje Ajdukovic,Douglas L. Arnold,Robert B. Gledhill,Ronald D. Guttmann,Paul C. Holland,P. Koch,Eric A. Shoubridge,Desmond G. Spence,Michel Vanasse,Gordon V. Watters,Michał Abrahamowicz,Catherine Duff,Ronald G. Worton	1993	235
8	Mapping of the Human NMDA Receptor Subunit (NMDAR1) and the Proposed NMDA Receptor Glutamate-Binding Subunit (NMDARA1) to Chromosomes 9q34.3 and Chromosome 8, Respectively Colin C. Collins,Catherine Duff,Alessandra M.V. Duncan,Rosa Planells‐Cases,William Sun,Anne Nørremølle,Elias K. Michaelis,Mauricio Montal,Ronald G. Worton,Michael R. Hayden	1993	15
9	The role of the skeletal muscle ryanodine receptor gene in malignant hyperthermia. David H. MacLennan,Kinya Otsu,Jun Fujii,Francesco Zorzato,Michael Phillips,Peter J. O’Brien,Alan Archibald,Beverley A. Britt,Elizabeth F. Gillard,Ronald G. Worton	1992	57
10	Linkage analysis in X-linked ocular albinism Rhonda E. Schnur,Robert L. Nussbaum,Lynn Anson‐Cartwright,Cathy McDowell,Ronald G. Worton,Maria A. Musarella	1991	31
11	Dystrophin is tightly associated with the sarcolemma of mammalian skeletal muscle fibers Elizabeth E. Zubrzycka‐Gaarn,O. F. Hutter,George Karpati,Henry J. Klamut,Dennis E. Bulman,Robert S. Hodges,Ronald G. Worton,Peter N. Ray	1991	31
12	A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia Elizabeth F. Gillard,Kinya Otsu,Junichi Fujii,Vijay K. Khanna,Stella de Leon,Jeanette Derdemezi,Beverley A. Britt,Catherine Duff,Ronald G. Worton,David H. MacLennan	1991	254
13	Genetic and Biochemical Determinations in the Pre-Transplant Workup and in the Post-Transplant Assessment Period Ronald G. Worton,Dennis E. Bulman,Elizabeth E. Zubrzycka‐Gaarn,P N Ray	1990	0
14	Age-Related Conversion of Dystrophin-Negative to -Positive Fiber Segments of Skeletal but not Cardiac Muscle Fibers in Heterozygote mdx Mice George Karpati,Elizabeth E. Zubrzycka‐Gaarn,Stirling Carpenter,Dennis E. Bulman,Peter N. Ray,Ronald G. Worton	1990	49
15	Prenatal identification of a girl with a t(X;4)(p21;q35) translocation: molecular characterisation, paternal origin, and association with muscular dystrophy. Sharon Bodrug,Jacquelyn Roberson,Lester Weiss,P N Ray,Ronald G. Worton,D L Van Dyke	1990	33
16	Differential Activation of the hprt Gene on the Inactive X Chromosome in Primary and Transformed Chinese Hamster Cells Stephen G. Grant,Ronald G. Worton	1989	7
17	Mapping of four translocation breakpoints within the Duchenne muscular dystrophy gene Sharon Bodrug,Arthur H.M. Burghes,Peter M. Ray,Ronald G. Worton	1989	15
18	Molecular Genetics of Duchenne and Becker Muscular Dystrophy Ronald G. Worton,Arthur H.M. Burghes	1988	17
19	A grandpaternally derived de novo deletion within Xp21 initially presenting in carrier females diagnosed as Kugelberg‐Welander syndrome Stephen Wood,Robert Shukin,Barbara McGillivray,Peter N. Ray,Ronald G. Worton,John M. Optiz,James F. Reynolds	1988	6
20	A (2;8) translocation, 46 chromosomes Ronald G. Worton,M.M. Aronson,A.E. Greene,L.L. Coriell	1977	1

About Ronald G. Worton

Ronald G. Worton is a scholar working on Molecular Biology, Genetics and Genetics, having authored 88 papers that have together received 5.0k indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (44 papers), CRISPR and Genetic Engineering (13 papers), RNA modifications and cancer (12 papers), Neurogenetic and Muscular Disorders Research (11 papers), RNA Research and Splicing (11 papers), Cardiomyopathy and Myosin Studies (9 papers), Virus-based gene therapy research (8 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (7 papers). The work is most often cited by research in Molecular Biology (4.4k citations), Genetics (667 citations) and Genetics (1.2k citations). Ronald G. Worton has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Peter N. Ray, Catherine Duff, Arthur H.M. Burghes, Elizabeth E. Zubrzycka‐Gaarn, George Karpati, Margaret Thompson, Dennis E. Bulman, Henry J. Klamut, Xiuyuan Hu and Cairine Logan.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact